Prolonged-release fampridine and active motor training in MS patients: a Phase IV, double-blind, placebo-controlled

被引：0
|
作者：
Jacques, F. H. [1 ]
Nativ, A. [2 ]
Schembri, A. J. [3 ]
Paquette, C. [1 ]
Kalinowski, P. [3 ]
机构：
[1] Clin Neurooutaouais, Gatineau, PQ, Canada
[2] Clin Neurogym, Gatineau, PQ, Canada
[3] CogState, Melbourne, Vic, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1321
引用
收藏
页码：698 / 698
页数：1
相关论文
共 50 条
  • [1] Prolonged-release fampridine as adjunct therapy to active enabled motor training in multiple sclerosis patients: a pilot, double-blind, placebo-controlled study
    Jacques, F.
    Schembri, A.
    Nativ, A.
    Paquette, C.
    Kalinowski, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 673 - 673
  • [2] Prolonged-Release Fampridine Treatment and Walking Speed in Japanese Patients with MS: Design of the Multicentre, Double-Blind, Randomised, Placebo-Controlled MOTION-JAPAN Study.
    Saida, T.
    Yokoyama, K.
    Masaki, K.
    McNeill, M.
    Mehta, L. R.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 423 - 423
  • [3] Treatment of fatigue in multiple sclerosis: a phase II double-blind, randomized, mono-center, placebo-controlled crossover-sub-study on prolonged-release fampridine
    Weller, D.
    Sutter, T.
    Koeszeghi, L.
    Kapitza, S.
    Reuter, K.
    Filli, L.
    Zoerner, B.
    Farkas, M.
    Weller, M.
    Linnebank, M.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 526 - 526
  • [4] Long-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE study
    Ziemssen, T.
    Hobart, J.
    Feys, P.
    Linnebank, M.
    Goodman, A.
    McNeill, M.
    Zhong, J.
    Mehta, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 621 - 621
  • [5] Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial
    Chavez-Iniguez, Jonathan S.
    Poo, Jorge L.
    Ibarra-Estrada, Miguel
    Garcia-Benavides, Leonel
    Navarro-Blackaller, Guillermo
    Cervantes-Sanchez, Cynthia
    Nungaray-Pacheco, Eduardo
    Medina-Gonzalez, Ramon
    Armendariz-Borunda, Juan
    Garcia-Garcia, Guillermo
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2021, 2021
  • [6] Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial
    Harandi, Ali Amini
    Pakdaman, Hossein
    Karamiani, Faezeh
    Mohammadi, Faezeh
    Barough, Siavash Shirzadeh
    Siavoshi, Fatemeh
    Ilkhani, Saba
    Sahraian, Mohammadali
    NEUROLOGICAL SCIENCES, 2023, 44 (01) : 393 - 396
  • [7] Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)
    Preiningerova, Jana Lizrova
    Baumhackl, Ulf
    Csepany, Tunde
    Czaplinski, Adam
    Deisenhammer, Florian
    Derfuss, Tobias
    Fabjan, Tanja H.
    Fazekas, Franz
    Fuchs, Siegrid
    Havrdova, Eva
    Ledinek, Alenka Horvath
    Illes, Zsolt
    Jazbec, Sasa Sega
    Klimova, Eleonora
    Komoly, Samuel
    Kurca, Egon
    Linnebank, Michael
    Lisy, Lubomir
    Mares, Jan
    Prochazkova, Lubica
    Csilla, Rozsa
    Szilasiova, Jarmila
    Stourac, Pavel
    Talab, Radomir
    Turcani, Peter
    Vachova, Marta
    Vecsei, Laszlo
    Vodusek, David
    Zapletalova, Olga
    Berger, Thomas
    CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (05) : 302 - 306
  • [8] Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial
    Ali Amini Harandi
    Hossein Pakdaman
    Faezeh Karamiani
    Faezeh Mohammadi
    Siavash Shirzadeh Barough
    Fatemeh Siavoshi
    Saba Ilkhani
    Mohammadali Sahraian
    Neurological Sciences, 2023, 44 : 393 - 396
  • [9] Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial
    Hupperts, Raymond
    Lycke, Jan
    Short, Christine
    Gasperini, Claudio
    McNeill, Manjit
    Medori, Rossella
    Tofil-Kaluza, Agata
    Hovenden, Maria
    Mehta, Lahar R.
    Elkins, Jacob
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (02) : 212 - 221
  • [10] Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial
    Trenkwalder, Claudia
    Chaudhuri, K. Ray
    Martinez-Martin, Pablo
    Rascol, Olivier
    Ehret, Reinhard
    Valis, Martin
    Satori, Maria
    Krygowska-Wajs, Anna
    Marti, Maria J.
    Reimer, Karen
    Oksche, Alexander
    Lomax, Mark
    DeCesare, Julia
    Hopp, Michael
    LANCET NEUROLOGY, 2015, 14 (12): : 1161 - 1170
12345